CL
AST.WS

CSS LLC’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

CSS LLC’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-129,837
Closed -$65K – 724
2017
Q2 		$65K Buy
129,837
+21,295
+20% +$9.63K ﹤0.01% 588
2017
Q1 		$46K Buy
+108,542
New +$39.9K ﹤0.01% 600

CSS LLC's AST.WS Position: Q3 2017 in Review

CSS LLC sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 129,837 shares — an estimated $65K sold.

CSS LLC first reported a position in AST.WS in Q1 2017 and held it in 2 quarters. The position peaked at $65K in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • CSS LLC reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • CSS LLC sold 129,837 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017, an estimated $65K.
  • CSS LLC first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q1 2017 and held it in 2 quarters.
  • CSS LLC's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $65K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on CSS LLC's 13F filing for Q3 2017, filed 14 Nov 2017.